RadNetRDNT
Market Cap: $4.62B
About: RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.
Employees: 10,288
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
22% more capital invested
Capital invested by funds: $2.95B [Q1] → $3.6B (+$650M) [Q2]
13% more funds holding in top 10
Funds holding in top 10: 8 [Q1] → 9 (+1) [Q2]
2% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 47
2% more repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 95
0% more funds holding
Funds holding: 273 [Q1] → 274 (+1) [Q2]
5.73% less ownership
Funds ownership: 88.53% [Q1] → 82.8% (-5.73%) [Q2]
23% less call options, than puts
Call options by funds: $9.34M | Put options by funds: $12.2M
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
Barclays Andrew Mok 80% 1-year accuracy 35 / 44 met price target | 27%upside $79 | Overweight Upgraded | 6 Sept 2024 |
Barclays Andrew Mok 80% 1-year accuracy 35 / 44 met price target | 9%downside $57 | Equal-Weight Maintained | 8 Aug 2024 |
Truist Securities David Macdonald 89% 1-year accuracy 24 / 27 met price target | 12%upside $70 | Buy Maintained | 15 Jul 2024 |
Jefferies Brian Tanquilut 75% 1-year accuracy 6 / 8 met price target | 20%upside $75 | Buy Maintained | 11 Jul 2024 |
Barclays Andrew Mok 80% 1-year accuracy 35 / 44 met price target | 18%downside $51 | Equal-Weight Maintained | 10 Jul 2024 |
Financial journalist opinion
Based on 3 articles about RDNT published over the past 30 days